244 related articles for article (PubMed ID: 26192107)
1. Ubc9 Impairs Activation of the Brown Fat Energy Metabolism Program in Human White Adipocytes.
Hartig SM; Bader DA; Abadie KV; Motamed M; Hamilton MP; Long W; York B; Mueller M; Wagner M; Trauner M; Chan L; Bajaj M; Moore DD; Mancini MA; McGuire SE
Mol Endocrinol; 2015 Sep; 29(9):1320-33. PubMed ID: 26192107
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Activity in Human White Adipocytes Is Regulated by the Ubiquitin Carrier Protein 9/microRNA-30a Axis.
Koh EH; Chen Y; Bader DA; Hamilton MP; He B; York B; Kajimura S; McGuire SE; Hartig SM
J Biol Chem; 2016 Nov; 291(47):24747-24755. PubMed ID: 27758866
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue.
Rosell M; Hondares E; Iwamoto S; Gonzalez FJ; Wabitsch M; Staels B; Olmos Y; Monsalve M; Giralt M; Iglesias R; Villarroya F
Endocrinology; 2012 Mar; 153(3):1162-73. PubMed ID: 22253419
[TBL] [Abstract][Full Text] [Related]
4. Role of UBC9 in the regulation of the adipogenic program in 3T3-L1 adipocytes.
Cignarelli A; Melchiorre M; Peschechera A; Conserva A; Renna LA; Miccoli S; Natalicchio A; Perrini S; Laviola L; Giorgino F
Endocrinology; 2010 Nov; 151(11):5255-66. PubMed ID: 20881252
[TBL] [Abstract][Full Text] [Related]
5. MiR-27 orchestrates the transcriptional regulation of brown adipogenesis.
Sun L; Trajkovski M
Metabolism; 2014 Feb; 63(2):272-82. PubMed ID: 24238035
[TBL] [Abstract][Full Text] [Related]
6. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
Mur C; Arribas M; Benito M; Valverde AM
Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
[TBL] [Abstract][Full Text] [Related]
7. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.
Kershaw EE; Schupp M; Guan HP; Gardner NP; Lazar MA; Flier JS
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1736-45. PubMed ID: 17848638
[TBL] [Abstract][Full Text] [Related]
8. C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists.
Vernochet C; Peres SB; Davis KE; McDonald ME; Qiang L; Wang H; Scherer PE; Farmer SR
Mol Cell Biol; 2009 Sep; 29(17):4714-28. PubMed ID: 19564408
[TBL] [Abstract][Full Text] [Related]
9. Ube2i deletion in adipocytes causes lipoatrophy in mice.
Cox AR; Chernis N; Kim KH; Masschelin PM; Saha PK; Briley SM; Sharp R; Li X; Felix JB; Sun Z; Moore DD; Pangas SA; Hartig SM
Mol Metab; 2021 Jun; 48():101221. PubMed ID: 33771728
[TBL] [Abstract][Full Text] [Related]
10. The SUMO conjugating enzyme Ubc9 is a regulator of GLUT4 turnover and targeting to the insulin-responsive storage compartment in 3T3-L1 adipocytes.
Liu LB; Omata W; Kojima I; Shibata H
Diabetes; 2007 Aug; 56(8):1977-85. PubMed ID: 17536066
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes.
Perwitz N; Wenzel J; Wagner I; Büning J; Drenckhan M; Zarse K; Ristow M; Lilienthal W; Lehnert H; Klein J
Diabetes Obes Metab; 2010 Feb; 12(2):158-66. PubMed ID: 19895638
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization.
Wang QA; Zhang F; Jiang L; Ye R; An Y; Shao M; Tao C; Gupta RK; Scherer PE
Mol Cell Biol; 2018 May; 38(10):. PubMed ID: 29483301
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-gamma activation and function in lipid homeostasis and energy expenditure.
Jin D; Guo H; Bu SY; Zhang Y; Hannaford J; Mashek DG; Chen X
FASEB J; 2011 Feb; 25(2):754-64. PubMed ID: 20974668
[TBL] [Abstract][Full Text] [Related]
15.
Saha PK; Hamilton MP; Rajapakshe K; Putluri V; Felix JB; Masschelin P; Cox AR; Bajaj M; Putluri N; Coarfa C; Hartig SM
Am J Physiol Endocrinol Metab; 2020 Oct; 319(4):E667-E677. PubMed ID: 32799658
[TBL] [Abstract][Full Text] [Related]
16. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
17. Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes.
Cai J; Shi X; Wang H; Fan J; Feng Y; Lin X; Yang J; Cui Q; Tang C; Xu G; Geng B
Biochim Biophys Acta; 2016 May; 1861(5):419-29. PubMed ID: 26946260
[TBL] [Abstract][Full Text] [Related]
18. Bmp4 Promotes a Brown to White-like Adipocyte Shift.
Modica S; Straub LG; Balaz M; Sun W; Varga L; Stefanicka P; Profant M; Simon E; Neubauer H; Ukropcova B; Ukropec J; Wolfrum C
Cell Rep; 2016 Aug; 16(8):2243-2258. PubMed ID: 27524617
[TBL] [Abstract][Full Text] [Related]
19. Quantitative image analysis in adipose tissue using an automated image analysis system: differential effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist on white and brown adipose tissue morphology in AKR obese and db/db diabetic mice.
Okamoto Y; Higashiyama H; Inoue H; Kanematsu M; Kinoshita M; Asano S
Pathol Int; 2007 Jun; 57(6):369-77. PubMed ID: 17539968
[TBL] [Abstract][Full Text] [Related]
20. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
